Tinasas, Cyford .

HRN: 29-23-65  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/03/2026
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
07/03/2026
07/10/2026
PO
5ML
Q8HRS
AMOEBIASIS
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: